Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) solicits R01 grant applications that would support independent research projects within the scientific mission areas of the participating NIH Institutes or Centers from a diverse cohort of New Investigators and At-Risk Investigators.

Deadlines:

Application Deadlines: Feb. 5, Jun. 5, Oct. 5

PAS-25-190 Expiration Date November 06, 2027

Specialties

Others

Eligibility Requirements

Institutions must ensure that individuals identified as the PD(s)/PI(s) meet one of the eligibility criteria A or B below (i.e., status as either a New Investigator or At-Risk Investigator). For applications with multiple PDs/PIs, each individual serving as PD/PI is required to meet one of the eligibility criteria A or B, (i.e., must be either a New or At-Risk Investigator). New and At-Risk Investigator status will be verified by NIH at the time of application.

A. New Investigator (NI)

For the purpose of this NOFO, an investigator is considered a New Investigator (NI) if they have not competed successfully for substantial, independent funding from NIH. A "substantial" research award is defined as any research grant award, with the exception of smaller grants that maintain Early Stage Investigator (ESI)/NI status (see full list of “smaller grant” awards that maintain Early Stage Investigator (ESI)/NI status). PD(s)/PI(s) of NIH Training-Related and Mentored Career Awards are still considered New Investigators if the NIH awards are in any of the following categories: fellowships (F awards), individual or institutional career awards (K awards), loan repayment contracts (L30, L32, L40, L50, L60), and all training grants (T32, T34, T35, T90, D43).

B. At-Risk Investigator

For the purpose of this NOFO, an investigator is considered an At-Risk Investigator (AR) if they have had prior support as a Principal Investigator (PD/PI) on a substantial independent research award from NIH and, unless successful in securing support from a substantial NIH research grant award in the current fiscal year, will have no substantial NIH research grant funding support in the following fiscal year. A "substantial" research award is defined as any NIH research grant award, with the exception of smaller grants that maintain ESI/NI status (see full list of “smaller grant” awards that maintain Early Stage Investigator (ESI)/NI status).

By the time of award, the PD/PI (or for a multiple PDs/PIs application, all PDs/PIs) must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity